3M Company (MMM)
MMM trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/66740/000006674026000014/0000066740-26-000014-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | MMM on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000066740 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $24.9B |
| Net income | $3.3B |
| Operating income | $4.6B |
| Net margin | 13.0% |
| Operating margin | 18.6% |
| Revenue growth | +1.5% |
| Cash | $5.2B |
| Total assets | $37.7B |
| P/E (computed) | 28.9× |
| P/S (computed) | 3.8× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-10-20 |
| Cash and burn | $4.8B cash; operating cash flow $907.3M a quarter. | Report 2026-09-30 |
| Shares outstanding | 516,729,574 (2026-09-30); 531,225,048 a year earlier; 552,317,038 three years earlier. 3y figure adjusted for splits (1.196-for-1 overall). | Cover page 2026-09-30 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 1 424B5 takedowns | Latest 2026-09-03 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25-NSE filed | 25-NSE 2026-11-09 |
| Auditor | PricewaterhouseCoopers LLP, Minneapolis, Minnesota, United States | PCAOB Form AP 2026-02-18 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $21.0M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $6.6B | $1.4B | $486.0M | $4.8B | $15.0B | $25.2B | 10-Q 2026-10-20 |
| Q2 2026 2026-06-30 | $6.5B | $933.0M | $986.0M | $3.0B | $12.6B | $25.2B | 10-Q 2026-07-21 |
| Q1 2026 2026-03-31 | $6.0B | $653.0M | $574.0M | $3.7B | $12.6B | $25.0B | 10-Q 2026-04-21 |
| Q4 2025 2025-12-31 | $6.1B | $577.0M | $1.6B | $5.2B | $12.6B | $24.9B | 10-K 2026-02-03 |
| Q3 2025 2025-09-30 | $6.5B | $834.0M | $1.8B | $4.7B | $12.6B | $24.8B | 10-Q 2026-10-20 |
| Q2 2025 2025-06-30 | $6.3B | $723.0M | -$954.0M | $3.7B | $13.1B | $24.6B | 10-Q 2026-07-21 |
| Q1 2025 2025-03-31 | $6.0B | $1.1B | -$79.0M | $6.3B | $13.5B | $24.5B | 10-Q 2026-04-21 |
| Q4 2024 2024-12-31 | $6.0B | $728.0M | $1.8B | $5.6B | $13.0B | $24.6B | 10-K 2025-02-05 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B2 | 2026-09-04 |
| Latest annual report | 10-K | 2026-02-03 |
| Latest quarterly / interim | 10-Q | 2026-10-20 |
| Latest current report | 8-K | 2026-11-04 |
| Latest proxy | DEFA14A | 2026-03-27 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.8% |
| 1 month | +12.8% |
| 3 months | +0.6% |
| Year to date | +14.7% |
| 1 year | +7.6% |
| From 52-week high | -5.3% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SYK | Stryker Corporation | $310.72 | +0.35% | $118.3B |
| BSX | Boston Scientific Corporation | $43.69 | -1.47% | $63.3B |
| BDX | Becton Dickinson and Company | $216.47 | -0.72% | $59.0B |
| MDLN | Medline Inc. | $39.17 | -0.76% | $51.5B |
| RMD | ResMed Inc. | $238.19 | -0.56% | $33.5B |
| DXCM | DexCom Inc. | $81.61 | -2.06% | $30.4B |
| WST | West Pharmaceutical Services Inc. | $417.80 | +0.33% | $29.1B |
| SOLV | Solventum Corporation | $88.65 | -0.48% | $15.0B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier